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In  classical  immune  cytolysis,  antibody bound  to  cell-surface  antigen  ini- 
tiates the lyric action of complement. It permits binding and activation of the 
first  component  of  complement  which  in  turn  catalyzes  binding  to  the  cell 
surface of the second and fourth components, setting in motion a  well defined 
chain  of events which  results in functional membrane impairment (1). 
In  this  paper  alternative  mechanisms  of  cell  lysis  by complement will  be 
described which are entirely independent of antibody. One mechanism of lysis 
of the nonsensitized target cell is initiated by the C4,2 enzyme  I either from the 
fluid phase or from the surface of another cell.  Action of the enzyme on sub- 
sequent complement proteins affects the "by-standing" target cell in a charac- 
teristic  manner.  Beginning  with  the  fifth  component,  activated  complement 
proteins become physically bound to the target cell,  which after reaction with 
C8  and  C9,  undergoes  lysis. Whereas  this  mechanism is relatively inefficient 
when  compared with  classical  immune cytolysis,  it points  out  the  possibility 
of a  lyric effect occurring  at some distance from the  site  of activation of the 
initially acting  complement components. Erythrocytes (E) from patients with 
paroxysmal nocturnal  hemoglobinuria (PNH)  2 were  found  to  be  particularly 
susceptible to lysis induced by fluid phase C4,2. 
Another  mechanism  of  nonimmune  lysis  involves  only  the  six  late-acting 
complement proteins and the C3 serum proinactivator (2). After its activation 
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in whole sheep or guinea pig blood,  complement-dependent  hemolysis has been 
reported  to occur  (3,  4).  It will be shown  that,  unlike normal human  erythro- 
cytes,  PNH  cells  are  exceptionally  susceptible  to  this  mode  of  hemolysis. 
The results contained in this paper have been presented  in part  in  the form 
of two abstracts  (5,  6). 
Materials and Methods 
Purified Complement Proteins and Complement Reagents.~Partially purified, macromolecu- 
lar CI was prepared from human serum according to Nelson (7) and Cls was isolated using 
either of the two published methods (8, 9). C2 was purified as described previously (10) and 
was used exclusively in its oxidized form (11).  C3  (12),  C4  (13),  C5  (12),  C8  (14),  and C9 
(15) were obtained according to published methods. 
Isolated C3 and C5 were utilized for quantitative uptake studies in radioactively labeled 
form. The chloramine T  method  (16) was used and  the average specific  radioactivity was, 
respectively, 50,000  and 120,000 cpm/#g of C3 and C5. 
Partially purified C6 was prepared  as follows.  The euglobulin  fraction was precipitated 
from serum by dialysis against a  0.008  M EDTA solution of pH 5.4  and  a  conductance at 
22°C  of 1.25 mmho/cm. The protein precipitate was dissolved in 0.02 ~  sodium phosphate 
buffer, pH 7.3,  containing approximately 0.2 ~  sodium chloride. After clearing the solution 
by centrifugation for 60 rain at 36,000  rpm in a Spinco No. 40 rotor  (Beckman Instrument 
Co.,  Spinco Division, Palo Alto,  Calif.),  it was dialyzed against  0.02  M sodium phosphate 
buffer, pH 7.3, overnight and applied to a 3.3 X  70 cm column of triethylaminoethyl (TEAE) 
cellulose equilibrated with buffer used for dialysis. The chromatogram was developed with a 
combined salt and  pH gradient, the limiting solution being 0.3 M NaH2PO4.  C6 was eluted 
between pH 6.5  and  6.0,  corresponding  to  a  conductance  range  of 6.0-7.5  mmho/cm.  C6 
activity was detected using washed, optimally sensitized sheep erythrocytes  (EA)  and  C6- 
deficient rabbit serum  (17). The fractions containing the greatest activity were pooled and 
concentrated by pressure filtration in an Amieon apparatus  (Amicon Corp., Lexington, Mass.) 
using a UM 10 membrane. The material was then further separated by chromatography on 
a 2.5 X  38 cm column of carboxymethyl (CM) Sephadex C-50 equilibrated with sodium phos- 
phate buffer, pH 6.0,  ionic strength 0.05,  containing sufficient NaC1  to yield a conductance 
of 10 mmho/cm. A NaC1 gradient was employed, the limiting conductance being 50 mmho/cm. 
C6 activity was eluted at a conductance range of 14.5-17.5  mmho/cm. This preparation was 
concentrated, frozen in liquid nitrogen, and stored at -  70°C and used throughout this study. 
Approximately 60 ng of the preparation gave 50% lysis of 5 X  107 EA in 60 rain at 37°C 
(total volume 1.5 ml), in presence of 6.6% of C6-deficient rabbit serum. 
Partially purified  C7  was prepared  from the pseudoglobulin fraction  of human  serum, 
i.e., the supernatant of the euglobulin preparation (see above). The pH of the protein solution 
(400 ml) was adjusted to 7.3 with 1 ~NaOH and the conductance was raised to 2.2 mmho/cm 
with NaC1. The material was applied to a 7.5 X  50 cm column of TEAE cellulose equilibrated 
with 0.02 ~  sodium phosphate buffer, pH 7.3, and was eluted stepwise with the same buffer 
containing NaC1 to yield 10 mmho/cm. The activity emerged within a conductance range of 
4.0-6.5 mmho/em. C7 activity was assayed with EAC1-3 plus an excess of C5, 6, 8, and 9. 
The active material was concentrated to 15 ml and applied to a 5 X  120 cm column of Seph- 
adex  G-200  equilibrated with 0.05  ~  tris(hydroxymethyl)aminomethane (Tris)-HC1  buffer, 
pH 8.0,  containing 0.50 ~  NaC1.  C7  activity was detected in fractions between the second 
and  third peak of the elution profile.  The active protein was then applied to a  2  X  30 cm 
column of P-cellulose (Cellex  P, Bio-Rad Laboratories, Richmond, Calif.) equilibrated with 
sodium  phosphate  buffer,  pH 6.0,  ionic strength  0.1.  After elution by NaC1  concentration 900  COI~fPLEMENT  LYSIS  OF  ERYTItROCYTES 
gradient, C7 activity was found in fractions of 17-23 mmho/cm. With the assay system used, 
approximately 280 ng of C7 gave 50% lysis of 5  X  107 cells in 60 rain at 37°C. 
In some experiments a  euglobulin subfraction was used as a  source for C3, 5, 6, 7, and 8 
(C3-8 reagent). This was obtained as described  (15). A reagent supplying C6-9 was prepared 
by  treating  guinea pig  serum  with  hydrazine  and  KCNS  (18)  and  diluting  it  in  isotonic 
NaCl-veronal buffer containing 0.1% gelatin and 0.02 M EDTA (GVBE)  of pH 7.4. 
Cobra Factor.--The cobra factor was isolated from lyophilized Naja naja venom purchased 
from Ross Allen Reptile Farm,  Silver Springs, Fla.  The method of isolation has previously 
been described  (19). 
Cells.--Sheep erythrocytes were purchased from the Colorado  Serum Company, Denver, 
Colo.  Normal  human erythrocytes were  obtained  from  laboratory  personnel.  Erythrocytes 
from four different patients with PNH were kindly supplied by Dr. Lawrence Petz, Harkness 
Community  Hospital,  San  Francisco,  Calif.  and  Doctors  Robert  Hartmann  and  David 
Jenkins, Nashville, Tenn. 
Conditions of Lysis of Nonsensitized  Erythrocytes.--In experiments where lysis was induced 
from  the fluid phase,  2  X  l0  s  washed erythrocytes  (sheep  E)  or  1  X  l0  s  human E  were 
packed by centrifugation into  the bottom of a  small test tube and the supernatant was re- 
moved with a  Pasteur pipette.  Usually C3,  5,  6,  and  7 were then added  and the cells sus- 
pended by use of a  Vortex mixer. After addition of C4,2  the reaction mixture was incubated 
for 20 min at 37°C. The diluent was GVBE, pH 6.5. The total reaction volume was 0.25-0.3 
ml. The cells were washed twice in GVBE  of pH  7.4 and suspended in 2  ml of this buffer. 
0.5 ml of the suspension was reacted with 1 ml of a solution of C8 and C9 for 60 min at 37°C. 
Controls included  2  X  0.5 ml of cell suspension plus 1 ml buffer and  1 ml distilled water, 
respectively.  The  free  hemoglobin  concentration  was  measured  spectrophotometrically  at 
412 nm. 
The C4,2  enzyme was prepared  by mixing, in a  total of  1 ml,  12  X  10  l° effective mole- 
cules of  °xyC2  (approximately  7 #g  protein),  3  X  10  l° effective molecules of  C4  (approxi- 
mately 3  #g protein),  and 0.75/zg of Cls. The pH was adjusted to 7.4 and the Mg ion con- 
centration  to  0.0005  M.  This mixture was incubated  at  37°C  for 30  min after which time 
EDTA  was added  to  a  final concentration of 0.02  M,  and  the pH  was lowered  to 6.5  with 
0.1 N HC1. The final volume was 1.5 ml, of which 0.05~0.1 ml were used per 2  X  l0  s sheep E 
or 1 X  l0  s human E, unless otherwise indicated. 
The amount of C3 used for the same number of cells was usually 20 #g and was varied 
in some experiments between 5 and 100 #g. The amount of C5 was generally 15 #g per tube 
and was varied in dose response experiments over a  10,000-fold range. C6 and  C7 were em- 
ployed in optimal concentrations, which cannot be defined by weight since only functionally 
pure  material was available.  C8  and C9 were  used in  amounts of  26  and 60 ng  per  tube, 
respectively. 
In experiments where target-cell lysis was induced by trigger cells, C4,2  or C4,2,3  were 
bound to the trigger cells according to published methods (20). The number of C4-~or C4,2,3 
complexes per  cell was 3000-5000.  Usually 1  X  10  s  51Cr-labeled  sheep E  was mixed with 
1  X  10  s trigger cells and a  cell button was formed by centrifugation. The supernatant was 
withdrawn and replaced  by 0.2 ml of a  solution of C3,  5,  6,  7 or C5,  6,  7  in pH 6.5 buffer. 
The mixture was incubated for 20 min at 37°C, washed twice in 4  ml pH 7.4 buffer,  resus- 
pended in 2 ml of the latter buffer and 3  X  0.5 ml of this suspension were treated and evalu- 
ated as described above for lysis induced from the fluid phase. 51Cr release was measured using 
1 ml of the cell-free supernatant obtained after completion of the reaction. 
In experiments where lysis of human erythrocytes was induced by cobra factor, 5  X  107 
red cells were incubated with 0.1 ml of a  blood group-compatible human serum in the pres- 
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justed to 8.0 and the Mg ion concentration  to 0.0005 ~. After 30 rain at 37°C, 2 ml of iso- 
tonic NaCl-veronal buffer containing 0.1% gelatin, 0.00015 M calcium,  and 0.0005 M mag- 
nesium  (GVB) of pH 8.0 was added to each tube and incubation was continued for another 
60 rain. 
Labeling of E with ~lCr.--lO  ml of sheep E containing  5 X  10  ~ cells were incubated with 
0.25q).5  mCi of 51Cr sodium  chromate  (New England Nuclear Corp.,  Boston,  Mass.)  for 
45 min at 37°C in GVBE of pH 6.5. The cells were washed with 5 X  10 ml of the same buf- 
fer and resuspended  to obtain the desired concentration.  The uptake of label corresponded 
to 20,000-40,000 cpm per 2 X  10  s cells. 
Serological Detection of Cell-Bound Complement Proteins.---Cell-bound C3, C4, or C5 were 
detected using monospecific complement  antisera and the microtiter technique  (Cooke En- 
gineering Co., Alexandria, Va.). 0.025 ml samples of 5 X  107 cells/ml were mixed with dilu- 
tions of the antisera ranging from  1:50 to 1:6400. The plates were kept for 20 rain at 37°C 
and overnight at 4°C, and the reaction was evaluated by reading the settling patterns. 
Cell-bound  C3  was also  detected by immune adherence  (21, 22) using lysates prepared 
from cell suspensions containing  5 X  1@ to 1 X  109 cells/ml. 
RESULTS 
Complement-Dependent Lysis  of Nonsensitized Sheep  Erythrocytes Initiated  by 
C4,2 in Free Solution 
Requirement of Components.--Treatment of nonsensitized sheep  erythrocytes 
(E)  with  C3,5,6,7  in  presence  of  preformed  C412  rendered  these  cells  sus- 
ceptible to lysis by C8  and  C9.  Similarly, incubation of E  with C3-8 in pres- 
ence  of  C4,2  caused  these  cells to  become  susceptible  to  the  action  of  C9. 
Since  treatment  of  E  was  performed  in  two  consecutive  steps  which  were 
separated by repeated washings of the cells, it is evident that the first treat- 
ment led to the formation of intermediate complexes carrying either C7  or C8 
sites. 
Deletion from the reaction mixture of either the activating enzyme C4,2  or 
the components C3-7 or C3-8 prevented lysis. Also, when E  was first incubated 
with  C4,2  plus C3  and then washed,  these cells were unable to undergo lysis 
upo___nn later  addition  of  C5-9.  The  latter  control  indicated  that  fluid  phase 
C4,2 did not form hemolytically active C3 sites on the surface of E. The results 
are summarized in Table I. 
Relationship  Between Lysis  of E  and  the Concentration of C4,2  and  C5.-- 
Fig.  1  shows  that lysis of E  is proportional to the concentration of the  C4,2 
enzyme in the reaction mixture.  In each of the two experiments depicted, the 
amounts  of the other complement proteins were  constant.  When  the  concen- 
tration of C5 was varied and that of all other proteins including C4,2 was kept 
constant,  lysis of E  was found to be proportional to C5  input (Fig. 2). 
Physical  Uptake of Complement Proteins by E.--Since E  treated  with  C3, 
5,6,7  and C4,2  acquired reactivity with C8 and C9,  the question arose as to 
which  complement proteins were  specifically bound  to  their  surface.  Qualita- 
tive  detection  was  attempted  using  antisera  to  three  different  complement 902  COMPLEMENT  LYSIS  OF  ERYTtIROCYTES 
proteins. In all of five separate experiments, treated E failed to react with anti- 
C3  and anti-C4,  but gave a definite agglutination reaction with anti-C5.  The 
absence of specifically bound C3 was further substantiated by the observation 
of  negative  immune  adherence  reactivity  (Table  II).  On  the  other  hand, 
TABLE  I 
Lysis of Nonsensitized Erythrocytes (E)  by Complement Following Activation in Free Solution 
Treatment of E 
Hemolysis 
I  II  III 
% 
C3-8  +  C4,2  --  C9  89.4 
C3-8  --  C9  1.8 
C3,5,6,7  n  u  C~,,2  --  C8,9  56.1 
C3,5,6,7  --  C8,9  3.9 
C4,2  --  C8,9  0 
C4,--2  --  C-EDTA  2.2 
C3  -k  C4-~  C5,6,7  C8,9  2.9 
Conditions: Treatment I: 2  X  108  E, reagents in 0.2 ml GVBE, pH 6.5, 20 rain at 37°C; 
the cells were then washed twice. Treatment II: conditions as in I. Treatment III: 5 X  107 E, 
reaction volume 1.5 ml, 60 rain at 37°C. 
1.0 
0.1 
0.01 // 
i  ~  i  ~  is 
Relative  Concentration  of  C4E~  - 
FIG.  1.  Dependence of lysis of nonsensitized sheep erythrocytes upon  the concentration 
of the C4,2  enzyme in the  reaction mixture. Two different amounts of C5 were chosen; the 
C4,2  concentration was varied over a  16-fold range, the concentration of all other comple- 
ment proteins was constant, y/1 -- y  =  1 corresponds to 50% lysis. OTTO  GOTZE  AND  HANS  J.  I~ULLER-EBERtLARD  903 
EAC4,2,3  and  EAC4,2,3,5  gave  strongly  positive  serological  reactions  as 
anticipated.  These findings indicated  that the treated E  cells which  could be 
lysed with C8  and  C9,  but lacked C3  and  C4,  were in  the state EC5,6,7. 
The serological data were confirmed and extended by quantitative  uptake 
studies  using  radiolabeled  C3  and  C5.  Table III lists  results  of  experiments 
with 125I-C3 in which the input of C3 was varied and in which uptake was de- 
termined in the presence and absence of C4,2 or C5,6,7. Compared to EAC4-~,  2, 
which showed a C3 uptake of 15 % of input or more than 14,000  molecules per 
20  t  .  1.0 
~0.21  ..........  2  5  10 
Micrograms C5 
50 
FIO. 2. Dependence of lysis of nonsensitized sheep erythrocytes upon C5 concentration. 
C5 input was varied from 4 to 35 #g. All other complement components were constant; the 
concentration of the C4,2 enzyme corresponded to 16 of Fig. 1. 
TABLE II 
Serological Analysis of Nonsensitized Erythrocytes (E) after Reaction with A ctivated 
Complement Components 
Agglutination by antiserum to 
Treatment  Immune adherence 
C3  C4  C5 
m 
E  +  C3,5,6,7  +  C4,2  0  0  +  0 
E  +  C3,5,6,7  0  0  0  0 
EAC4,2,3  +  +  0  + 
EAC4,2,3,5  +  +  +  + 
cell,  the nonsensitized  E  exhibited an uptake of approximately 1%.  Controls 
lacking the C4,--2 enzyme or EAC1,4 cells treated with C3 similarly took up 1% 
of the amount of C3 offered. Thus,  there was no detectable significant specific 
C3 uptake by E. Furthermore, E, having bound a  total of 1080  C3 molecules 
per  cell,  were  entirely  negative  in  the  anti-C3  agglutination  reaction.  This 
test detects as few as 100 specifically bound  C3 molecules per cell. 
In the case of C5, uptake by EAC4,2,3 was 1.9 % of input____, in agreement with 
previous  studies  (18).  Nonspecific  adsorption  to  EAC4,2  was  0.95%.  The 
specific uptake  therefore may be calculated  to be  1%  or  1480  molecules per 
cell.  Similarly, the specific uptake of C5 by nonsensitized E  was approximately 
1%  of input,  corresponding in  two  experiments respectively to  600  and  438 904  COMPLEMENT  LYSIS  OF  ERYTHROCYTES 
C5  molecules per  cell.  This degree  of  C5  binding must be  considered highly 
significant (Table IV). In addition, these cells could be agglutinated with an 
anti-C5 serum as indicated in Table II. The control cells with nonspecifically 
adsorbed C5 on their surface gave no agglutination reaction. 
TABLE  III 
Uptake of 125I-C3 by Nonsensltlzed Erythrocytes (E) Following Activation in Free Solution 
Uptake 
t~I-- C3  Specific  uptake* 
input  Reaction mixture  Molecules/  Molecules/cell  Lysis 
Input  cell 
(t~g)  (%) 
5.5  E  +  C3,5,6,7  +  C4,2  1.31  1,080 
5.5  E  +  C3,5,6,7  0.73  602 
18  E  +  C3,5,6,7  +  C4,2  0.73  1,970 
18  E  +  C3,5,6,7  1.17  3,159 
6.4  E  +  C3  +  C4,2  1.38  1,324 
6.4  E  +  C3  0.74  710 
18  E  +  C3  +  C4,2  0.20  540 
18  E  -I- C3  0.38  1,020 
6.4  EAC4,2  +  C3  15.41  14,793 
6.4  EAC4  +  C3  1.17  1,123 
18  E  +  C3i  1.16  3,130 
(%) 
478  58.0 
4.3 
--1,189  54.8 
5.8 
614  ND~ 
ND 
--480  ND 
ND 
13,670  ND 
ND 
Conditions: 2 X  10 s cells, reagents in 0.2 ml GVBE, pH 6.5, 20 rain, 37°C. The cells 
were then washed five times and uptake of l~SI  was measured. To determine  the degree of 
hemolysis, 5 X  10  7 treated cells were incubated with C8 and C9 in a total volume of 1.5 ml 
for 60 rain at 37°C. 
* Difference between uptake in presence and absence of C4,2. 
:~ Not determined. 
Complement-Dependent  Lysis of Nonsensitized  Sheep  Erythrocytes  Triggered by 
EAC4,2 or EAC4,2,3 
Requirement of Components.--The results obtained so far raised the question 
whether the activating enzyme may be bound to one cell and yet mediate up_ 
take  of  C5,6,7  by another cell.  Therefore,  EAC4,2,3  was  mixed with  51Cr- 
labeled E  and the cell mixture was treated first with C5,6, 7, washed, and then 
with C8 and C9. As shown in Table V, 51Cr was released under these conditions, 
indicating lysis of 25 %  of E  present. In addition, there was complete lysis of 
the  trigger  cells,  EAC4,2,3.  There  was  no  chromium release  when  C3  was 
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C5,6,7, when activated by cell-bound C4,2,3, may transfer and become bound 
to  an  adjacent  target  cell,  thereby initiating the  cytolytic reaction. 
To  determine  whether  a  hemolytically reactive  EC5  intermediate  can  be 
prepared the following experiment was carried out. EAC4,2,3  was mixed wim 
51Cr E  and the mixture was treated for 10 rain at 30°C with various amounts of 
C5.  The  cells were  then washed  and  reacted with  a  reagent containing  C6-9. 
TABLE IV 
Uptake of 1251-C5 by Nonsensitized Erythrocytes (E) Following Activation in  Free Solution 
Uptake 
12~I-C5  Specific uptake*  input  Reaction mixture  Lysis  Input  Molecules/  Molecules/cell 
cell 
(~g)  (%)  (%) 
4  E  +  C3,5,6,7  +  C4,2  2.51  1,506  438  13.3 
4  E  +  C3,5,6,7  1.78  1,068  0.2 
4  E  +  C3,5,6,7  +  C4~,2  2.65  1,590  600  35.4 
4  E  +  C3,5,6,7  1.65  990  6.6 
10  EAC4  +  C5,6,7  0.90  1,350  ND:~ 
10  EAC4-~  +  C5,6,7  0.95  1,420  ND 
10  EAC4,---~,3  +  C5,6,7  1.93  2,900  1,480  ND 
Conditions: See Table IlL 
* Difference between uptake in presence and 
:~ Not determined. 
absence of C4,2. 
TABLE V 
Lysis of Nonsensitized Erythrocytes (E) by C5-C9 after Activation by EA C4,2,3 
Reaction mixture  Lysis of E  Lysis of EAC 
No.  %  No.  % 
E +  EAC4,2,3 +  C5,6,7  2 X  107  25  2 X  107  100 
E +  EAC4,2 +  C5,6,7  0  0  0  0 
Conditions: 2 X  107 EAC, 8 X  107 E; reagents in 0.2 ml GVBE,  pH 6.5; incubation, 
30 rain at 37°C, followed by washing  and exposure to C8,9 for 60 min at 37°C. E labeled 
with 51Cr; lysis of E measured by 51Cr release. 
The amount of chromium released appeared insignificant and bore no relation- 
ship to the increasing amounts of C5 added (Table VI). It was concluded that 
C5 cannot be bound to E  specifically and in hemolytically active form without 
C6 and C7. 
Dependence of Lysis of E  Upon C__ell Concentration.--Fig. 3 demonstrates that 
lysis of nonsensifized E  by EAC4,2 and C3-9 is markedly dependent on a high 
cell concentration.  Lysis of  E  was  44%  at  the  highest  concentration  tested 906  COMPLEMENT  LYSIS  OF ERYTHROCYTES 
TABLE  VI 
Failure  of Activated  C5 to Bind in Hemolytically  Active  Form to E  i~ Absence  of C6 and C7 
Treatment after reaction 
C5 input  with C5 
Lysls of 
E  EAC4,2,---3 
(~g)  (%)  (%) 
2.5  C6-9  2.6  100 
5  C6-9  2.6  100 
10  C6-9  2.8  100 
20  C6-9  3.3  100 
2.5  C8,9  0.2  1.7 
5  C8,9  0.2  1.2 
10  C8,9  0.2  1.7 
20  C8,9  0.2  1.9 
--  C6-9  0.2  11.5 
--  C8,9  0.2  2.6 
Conditions: 10 s E  and 108 EAC412,3  in GVBE, pH 6.5, were treated with C5 for 10  rain 
at 30°C in a  total volume of 0.3 ml. The cells were washed twice, resuspended with 0.2 ml 
C6-9 or C8 and C9 and incubated for 20 rain at 37°C. To every tube was then added 2.0 ml 
of GVBE,  pH  7.4,  and incubation  was continued for another 60 rain.  E  was labeled with 
5ICr and lysis of E was detected by 51Cr release. 
4. 
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FIG.  3.  Dependence of lysis of nonsensitized sheep erythrocytes upon the cell concentra- 
tion.  2  )<  107  EAC4,2  and  8  )<  107  ~lCr-labeled E  were incubated together in increasing 
volumes of the same dilution of C3-C8. After 20 rnin at 37°C the cells were washed and lysed 
with C9. The upper curve (Hb release) shows the total number of cells lysed; the lower curve 
(htCr release)  shows the number of E  lysed. The horizontal line indicates the  (calculated) 
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(6.6  X  los  cells/ml)  and  sharply  decreased  to  less  than  10 %  at  2.8  X  10  s 
cells/rnl. 
Comparative Efficiency of C5 in the Lysis of E  and EAC4,2,3.--Equal  num- 
bers of 5tCr E  and  EAC4,2,3  were mixed and were reacted  at a  cell concen- 
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FiG. 4. Comparative  efficiency of C5 in lysing E and EAC4,2,3. Equal numbers of 5iCr- 
labeled E and EAC4,2,3 were reacted with C5-C9 in the same reaction mixture. The C5 in- 
put was varied between 0.04 ng and  10 #g. The concentration  of all other  components was 
constant.  Lysis of EAC4,2,3 was calculated  from the total hemoglobin release and  the re- 
lease of SZCr. 
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Fla. 5. Dependence of lysis of nonsensitized PNH and normal  human erythrocytes  upon 
the concentration  of C4,2,3 in the reaction mixture.  The C4,2,3 concentration  was varied 
over a fourfold range, whereas the concentration  of the other  complement  components was 
constant.  Erythrocytes from two patients with PNH and from three normal individuals were 
used. 
tration  of  6.6  X  l0  s  cells/ml with  C5-9.  Whereas  all  other  parameters  were 
constant,  the C5 concentration was varied from 0.04 ng to  10 pg. As shown in 
Fig, 4,  50%  lysis of EAC4,2,3 was obtained with 0.34 ng of C5,  whereas the 
same degree of lysis of E  required 4.1  tzg of  C5. 908  COMPLEMENT LYSIS OF  ERYTHROCYTES 
Complement-Dependent Lysis of PNH and Normal Human Erythrocytes Initiated 
in Free Solution 
Relationship  Between Lysis and the Concentralion of C4,2,3 and C5.--Fig. 5 
shows the extent of lysis of PNH and normal human erythrocytes as a function 
of C4,2,3  concentration. 50 %  lysis of PNH  cells was observed with a  relative 
amount of C4,2,3  of 1.5  and  the same degree of lysis of normal cells was ob- 
0,4. 
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FIG. 6. Dependence of lysis of nonsensltized  PNH and normal human erythrocytes upon 
the C5 concentration. 
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FlC. 7. Comparison of the binding efficiency of activated C5 by PNI-I and normal human 
erythrocytes. PNHE and E were each incubated with varying amounts of  125I-C5 and con- 
stant amounts of C4,2, C3, C6, and C7. After 20 rain at 37°C, the cells were washed  and 
the uptake of radiolabel was determined. 
tained within  a  relative amount  of 2.2-3.4.  Lysis of these  two  types of cells 
as a  function  of  C5  concentration  is demonstrated  in  Fig.  6.  To  achieve the 
same degree of lysis, 3.5-11  ~g of C5  were required for PNH  cells and  23-100 
~g of C5 for normal cells. 
Relationship  Between C5  Uptake and Cell Lysis.--Under  identical conditions 
and in the presence of fluid phase C4,2,3  PNH erythrocytes bound more than 
three times the number of C5 molecules than normal human  erythrocytes (Fig. 
7).  The  degree  of  ensuing  hemolysis was  proportional  to  the  number  of  C5 OTTO  GOTZE  AND  HANS  J.  MULLER-EBERHARD  909 
molecules bound. When the same number of C5 molecules had become bound 
to either cell type, the same degree of hemolysis was observed (Fig. 8). 
Complement-Dependent Lysis of PNH Erythrocytes Triggered by Cobra Factor. 
--Isolated cobra  factor  was  used  to  activate  the  C3  serum  proinactivator. 
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Fro. 8. Comparison of the hemolytic efficiency  of C5 bound to PNH and to normal human 
erythrocytes. Same experiment as Fig. 7. Lysis was determined after incubation of the washed 
cells with C8 and C9. 
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Fio. 9. Comparison of lysis of PNH and normal human erythrocytes  induced by cobra 
factor. S X 10  T  cells were incubated with 0.1 ml of blood group-compatible serum and varying 
amounts of cobra factor in a total volume of 0.310 ml. The diluent was GVB, pH 8.0. After 
3(1 rain at 37°C, 2.0 ml of GVB o£ pl--I  8.0 were added to each tube and incubation was con- 
tinued for another 60 rain. 
Addition of  increasing amounts of  cobra factor  to  samples  of  human serum 
containing PNH cells and incubation at 37°C and pH 8.0 led to development of 
marked  hemolysis  (Fig.  9).  Subsequent  examination  of  lysed  and  uulysed 
cells with antisera to complement proteins gave positive agglutination reactions. 
Normal human erythrocytes were unaffected by this mechanism of hemolysis. 910  COMPLEMENT  LYSIS  OF  ERYTHROCYTES 
DISCUSSION 
The  present  experiments  define  a  new  pathway  of  complement-mediated 
hemolysis which is not dependent on the participation of antibody and on the 
presence of the first four complement components at the surface of the target 
cells.  The attack of complement proteins on the target cell membrane begins 
with  C5  and  involves only the five terminal  components.  This  study repre- 
sents  a  detailed  exploration  of  preliminary  observations  which  were  made 
several years ago  (23).  The mechanism described resembles,  to a  certain ex- 
tent,  that postulated by Yachnin for PNH-cell lysis (24)  and may be related 
to the mechanism underlying the phenomenon of reactive hemolysis reported 
by Thompson and Lachmann (25). The results demonstrate that activated C5 
in  the presence of C6 and  C7  may bind directly and in hemolytically active 
form to receptors of unsensitized erythrocytes. They show that  C5,  C6,  and 
C7  act as a  functional unit in this reaction and  that  the  three proteins can 
transfer from the site of activation on one cell to the site of binding on another 
cell. 
The nature of the binding site of C5  in classical immune hemolysis is still 
unknown,  although it has been clearly shown that firm, physical binding of C5 
is a prerequisite of the formation of hemolytically active C5 sites on the cell 
surface  (26-28).  Shin et al.  (28)  believe guinea pig  C5  to be bound  in  close 
proximity to the  C2  and  C3  molecules on EAC4,2,3,5.  This  assumption  is 
based on their observation that C5 is dissociated from cells concomitant with 
the  decay-release of  C2.  Release  of  specifically bound  l~sI-C5 could  not  be 
demonstrated for the human analog, neither in conjunction with C2  release nor 
as  a  consequence of decay of cell-bound hemolytic  C5-sites  (18).  Thus,  the 
hypothesis that the receptor of C5 is the  C4,2,3 complex can neither be veri- 
fied nor refuted on the basis of this study. However, the reported formation of 
EC5,6,7  cells  shows  that  C5,6,7  sites may be established directly on  mem- 
brane receptors without the previous binding to this membrane of C4,2,3  or 
of antibody. 
Specific binding of C5 by E  required the participation of C6 and C7, since a 
hemolytically reactive EC5 complex could not be formed. This is in contrast to 
C5  binding by EAC4,2,3,  which proceeds in absence of C6 and C7  (26-28). 
But even in  the classical immune hemolytic reaction,  C6 and  C7  greatly en- 
hance C5  action by facilitating attachment of activated C5  molecules to the 
cell surface (18). Thus,  it appears most probable from this and other studies 
(18, 26) that C5, C6, and C7 constitute a functional unit, although under speci- 
fied conditions C5 can act independently of C6 and C7. 
Comparing the effect of C5-C9 on E  and on EAC4,2,3 present in the same 
reaction mixture disclosed  a  large quantitative difference in  lysis  of the  two 
cell  types.  Whereas  under  otherwise identical  conditions  lysis  of EAC4,2,3 
proceeded with nanogram amounts of C5, lysis of E required microgram quan- OTTO GOTZE AND IIANS J. NIiJLLER-EBERIIARD  911 
tities. This difference may indicate that successful binding of activated C5,6,7 
is more likely to occur in the proximity of the activation site (C4-, 2,3) than at 
some distance from it. In agreement with this assumption,  the degree of lysis 
of E  was found to be proportional to cell concentration, i.e., inversely propor- 
tional to the average distance between trigger and target cells.  If nonimmune 
cytolysis should occur in vivo, the prevailing conditions would be more favor- 
able than the optimal conditions employed in these experiments; in vivo the 
local cell concentration is generally high and so is the concentration of comple- 
ment proteins in plasma. 
Binding of C5,6,7 to target cells (E) after activation by trigger ceils (EAC 
4,2,3)  requires  transfer  of  the  activated  components.  Transfer  of  C5,6,7 
from the site of activation on one cell to the site of binding on another cell is 
distinct from any other known or postulated transfer phenomenon of comple- 
ment components. It is reminiscent of the transfer of activated C3  (1) which 
was  deduced from electron microscope evidence (29).  C3  transfer,  however, 
appears to occur only between an activation site  (C4~,2) and a  receptor site 
located on the same cell.  C3 fails to achieve binding to a cell following activa- 
tion in the fluid phase or at the surface of an adjacent cell. The C5,6, 7 transfer 
is  also distinct from transfer of C5  from EAC4,2,3,5  to EAC4,2,3,  which 
Shin et al.  (28)  postulated for guinea pig complement. Here,  a  C5  molecule 
which was previously bound to a C4,2,3 receptor site is assumed to transfer to 
other C4,2,3 sites, including those located on other cells. A completely differ- 
ent type of reaction is the well documented transfer of C1  between antibody 
sites of the same or of different cells (30). This process is due to the relatively 
weak binding of C1 to immunoglobulins and to the stability of the C1 combin- 
ing site. In contrast, the binding potential of other activated complement pro- 
teins, including C5,6,7, is labile; however, once binding has occurred the bond 
is usually much firmer than that of C1. Thus, the ability of C5,6,7 to transfer 
from the activation site (trigger cell) to a relatively distant binding site (target 
cell), suggests that the half-life of the activated combining site is not as short 
as in the case of C3. The experimental conditions which allowed effective trans- 
fer of C5,6,7 between trigger and target cells permit estimation of the maxi- 
mal life span  of the  C5,6,7  combining potential. The inflection point of the 
51Cr release curve in Fig. 3 was determined by extrapolation of the two straight 
portions of the curve. It corresponds to a reaction volume of 0.3 ml. Since the 
total number of cells present was 108, the average distance (d) between the cells 
in suspension was calculated to be 2.6  X  10  -4 cm, assuming a mean diameter 
for sheep erythrocytes of 4 X  10  4  cm. The approximate time (t) required for 
the activated trimolecular complex, (C5,6,7) to diffuse over the distance d  is: 
t  -- d2/2D  =  0.1  sec.  For  D,  the  diffusion  coefficient of  (C5,6,7)  at 37°C, 
a  value of 3.3  X  10  -7  cm2/sec was  assumed.  It  may be  inferred from these 
considerations that the maximal life span of the activated binding site of C5, 912  COMPLEMENT  LYSIS OF ERYTHROCYTES 
6,7 is smaller than or equal to 0.1 sec, and that this permits the activated com- 
plex to react with receptors which are separated from the site of activation by 
maximally 2.5 ~. 
Although most of the work has been done with sheep erythrocytes, similar 
results  were  obtained  with  normal  human  E  and  particularly with  PNHE. 
The latter are known to be considerably more susceptible to lysis by comple- 
ment than normal cells (31). This greater susceptibility can in part be explained 
in this study by the ability of PNH cells to bind a larger number of C5 mole- 
cules than normal human red cells. In addition, PNH cells exhibited a marked 
susceptibility to lysis triggered by cobra factor. This protein had previously 
been shown to combine with a fi-globulin when added to serum and to form an 
enzymatically active complex which is able to cleave C3 in a manner analogous 
to C4,--2 (2). Recently, Picketing et al. (3)  and Ballow and Cochrane (4) dem- 
onstrated that cobra factor could induce lysis of unsensitized sheep or guinea 
pig erythrocytes by autologous serum.  It is  pr___obable that  the  cobra factor- 
B-globulin complex can substitute for the  C4,2  enzyme and thus activate in 
typical fashion the late-acting complement proteins. It is further probable that 
cobra factor analogs occur in the  mammalian organism  which are capable of 
activating  the fi-globulin in  vivo.  Similarly,  formation of  the  C4,2  enzyme 
might occur in vivo through antibody-independent activation of C1 which has 
been achieved in vitro by plasmin, trypsin (32), and kallikrein (33). Thus, both 
mechanisms  might  conceivably be  operative in  complement-dependent non- 
immune cytolysis in vivo. 
The concept emerging from this  work may be formulated as  follows.  The 
C5,6,7  complex following  enzymatic  activation  of  its  combining  site  can 
transfer to a receptor site on the surface of nonsensitized cells  which contain 
no measurable amounts of either C2,  C3,  or C4. Bound C5,6,7 can then react 
with  C8 and C9, following which the cell undergoes lysis.  The C4,2,3 enzyme 
can act either from the fluid phase or from the surface of another cell. Since C8 
and  C9  are unable  to cause lysis of E  in  the presence of EAC4,2,3,5,6,7, * 
it  appears  that  direct  attack  of  complement  on  a  target membrane  cannot 
start later than at  the  C5,6,7  step.  These findings allow an operational dis- 
tinction between an activation mechanism of complement, consisting of C1,2,3 
and C4,  and an attack mechanism comprising C5,6,7,8 and C9. 
SUIfI~ARY 
A  new  pathway  of  complement-mediated  hemolysis  has  been  described. 
It is  independent of antibody and  does not require binding of the first four 
complement components to the target-cell surface.  The actual  attack  of the 
target cell begins with the attachment of C5,  C6, and C7. The binding reaction 
is catalyzed by C4,2,3,  an enzyme which may be formed in cell-free s~lution. 
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C4,2,3 may effect binding of C5,6,7 by acting from the fluid phase or from the 
surface of another cell to which it is specifically bound  (EAC4,2,3). In  either 
case, the resulting product is EC5,6,7  which is susceptible to lysis by C8  and 
C9. 
Erythrocytes  from  patients  with  paroxysmal  nocturnal  hemoglobinuria 
(PNH)  were particularly susceptible to lysis by the  above described  mecha- 
nism.  PNH  cells,  but  not  normal  human  erythrocytes,  could  also  be  lysed 
through  activation of complement by cobra factor. These observations allow 
the operational distinction of an activation and an attack mechanism of com- 
plement. 
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